Endsulin
WI - MadisonBiotechnology
Focus: Endsulin is a biotechnology company focused on genetic therapy for type 1 diabetes, operating in the metabolic and rare diseases space from Madison, Wisconsin.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at Endsulin?
AI assessmentEndsulin represents a high-risk, high-reward pre-revenue genetics play suitable only for mission-driven scientists and regulatory professionals willing to bet on undisclosed funding and an immature pipeline.
Why Work Here
- Opportunity to work on a potentially transformative genetic therapy approach to type 1 diabetes, a high-unmet-need metabolic disease affecting millions globally.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Help build intelligence for Endsulin
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.